These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37950594)

  • 1. Survival outcomes of 2018 FIGO stage IIIC versus stages IIIA and IIIB in cervical cancer: A systematic review with meta-analysis.
    Zhang Y; Wang C; Zhao Z; Cheng L; Xu S; Xie P; Xie L; Zhang S
    Int J Gynaecol Obstet; 2024 Jun; 165(3):959-968. PubMed ID: 37950594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer.
    Long X; He M; Yang L; Zou D; Wang D; Chen Y; Zhou Q
    Clin Med Insights Oncol; 2023; 17():11795549221146652. PubMed ID: 36726607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study.
    Li Z; Duan H; Guo J; Yang Y; Wang W; Hao M; Li W; Li P; Bin X; Lang J; Liu P; Chen C
    Ann Transl Med; 2022 Jan; 10(2):122. PubMed ID: 35282078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage migration and survival outcomes in patients with cervical cancer at Stage IIIC according to the 2018 FIGO staging system: a systematic review and meta-analysis.
    Han L; Chen Y; Zheng A; Tan X; Chen H
    Front Oncol; 2024; 14():1460543. PubMed ID: 39411135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study.
    Duan H; Li H; Kang S; Zhao H; Chen B; Wang L; Li P; Wang Y; Wang W; Lang J; Liu P; Chen C
    Acta Obstet Gynecol Scand; 2023 Aug; 102(8):1045-1052. PubMed ID: 37338046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphadenectomy increases the prognostic value of the revised 2009 FIGO staging system for endometrial cancer: a multi-center study.
    Kim HS; Kim HY; Park CY; Lee JM; Lee JK; Cho CH; Kim SM; Kim JW
    Eur J Surg Oncol; 2012 Mar; 38(3):230-7. PubMed ID: 22244682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer.
    Chang H; Wang M; Liu Y; Wu Y
    J Gynecol Oncol; 2023 Jul; 34(4):e46. PubMed ID: 36929577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
    Kim J; Cho Y; Kim N; Chung SY; Kim JW; Lee IJ; Kim YB
    Gynecol Oncol; 2021 Mar; 160(3):735-741. PubMed ID: 33358037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the 2018 FIGO cervical cancer staging system.
    Matsuo K; Machida H; Mandelbaum RS; Konishi I; Mikami M
    Gynecol Oncol; 2019 Jan; 152(1):87-93. PubMed ID: 30389105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the 2018 FIGO Staging System of Cervical Cancer for Stage III Patients with a Cohort from China.
    Liu X; Wang J; Hu K; Zhang F; Meng Q; Wang W; Wang D; Zhou Z; Ren K
    Cancer Manag Res; 2020; 12():1405-1410. PubMed ID: 32161492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of the presence of pelvic and/or para-aortic lymph node metastases in cervical cancer patients; the influence of the new FIGO classification (stage IIIC).
    van Kol KGG; Ebisch RMF; van der Aa M; Wenzel HB; Piek JMJ; Bekkers RLM
    Gynecol Oncol; 2023 Apr; 171():9-14. PubMed ID: 36804623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
    Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
    Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems.
    Shin W; Ham TY; Park YR; Lim MC; Won YJ
    Sci Rep; 2021 Mar; 11(1):6988. PubMed ID: 33772044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of tumor size and number of positive nodes in patients with FIGO 2018 stage IIIC1 cervical cancer.
    Maeda M; Mabuchi S; Sakata M; Deguchi S; Kakubari R; Matsuzaki S; Hisa T; Kamiura S
    Jpn J Clin Oncol; 2024 Feb; 54(2):146-152. PubMed ID: 37935434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system.
    McComas KN; Torgeson AM; Ager BJ; Hellekson C; Burt LM; Maurer KA; Werner TL; Gaffney DK
    Gynecol Oncol; 2020 Jan; 156(1):85-92. PubMed ID: 31744640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the New FIGO Classification for Cervical Cancer on Patient Survival: A Retrospective Analysis of 265 Histologically Confirmed Cases with FIGO Stages IA to IIB.
    de Gregorio A; Widschwendter P; Ebner F; Friedl TWP; Huober J; Janni W; de Gregorio N
    Oncology; 2020; 98(2):91-97. PubMed ID: 31593942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
    Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17).
    Yoon MS; Park W; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Chang SK; Lee KK; Kim M
    Gynecol Oncol; 2015 Sep; 138(3):519-25. PubMed ID: 26115977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
    Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic performance of the 2023 FIGO staging schema for endometrial cancer.
    Matsuo K; Chen L; Klar M; Lee MW; Machida H; Mikami M; Muderspach LI; Carlson JW; Roman LD; Wright JD
    Gynecol Oncol; 2024 Aug; 187():37-45. PubMed ID: 38713997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.